|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [745]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [745]
vin, T. R., Colligan, R. C., Offord, K. P., et al. (1996). Nicotine patch therapy in adolescent smokers. Pediatrics, 98 (4 Pt. 1), 659–667.
Solhkhah, R., & Wilens, T. E. (1998). Pharmacotherapy of adolescent AOD use disorders. Alcohol Health and Research World, 22, 122–126.
Spear, L. P. (2002). The adolescent brain and the college drinker: Biological basis of propensity to use and misuse alcohol. Journal of Studies on Alcohol Supplement, 14, 71–81.
Spencer, T., Heiligenstein, J. H., Biederman, J., Faries, D. E., Kratochvil, C. J., Conners, C. K., et al. (2002). Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63, 1140–1147.
Spielman, A. I., Najai, H., Sunavala, G., Dasso., M., Breer, H., Boekhoff, I., et al. (1996). Rapid kinetics of second messenger production in bitter taste. American Journal of Physiology, 270(3 pt 1), C926–931.
Spitz, M., Shi, H., Yang, F., Hudmon, K., Jiang, H., & Chanberlain, R. (1998). Case–control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. Journal of the National Cancer Institute, 90, 358–363. 
Spoth, R., Greenberg, M., Bierman, K., & Redmond, C. (2004). PROSPER partnership model for state public education systems: Capacity-building for evidence-based, competence-building prevention. Prevention Science, 5, 31–39.
Spoth, R., Guyll, M., & Day, S. X. (2002). Universal family-focused interventions in alcohol-use disorder prevention: Cost-effectiveness and cost-benefit analyses of two interventions. Journal of Studies on Alcohol, 63, 219–228.
Spoth, R., Redmond, C., & Shin, C. (2000). Reducing adolescents' aggressive and hostile behaviors: Randomized trail effects of a brief family intervention four years past baseline. Archives of Pediatrics and Adolescent Medicine, 154, 1248–1257.
Spoth, R. L., & Greenberg, M. T. (in press). To-ward a comprehensive strategy for effective practitioner-scientist partnerships and larger-scale community benefits. American Journal of Community Psychology.
Stitzer, M. L., & Bigelow, G. E. (1978). Contingency management in a methadone maintenance program: Availability of reinforcers. International Journal of the Addictions, 13, 737–746.
Stitzer, M. L., Iguchi, M. Y., Kidorf, M., & Bigelow, G. E. (1993). Contingency management in methadone treatment: The case for positive incentives. In L. S. Onken, J. D. Blaine, & J. J. Boren (Eds.), Behavioral treatments for drug abuse and dependence (pp. 19–36). Rockville, MD: National Institute on Drug Abuse.
Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. Journal of Nervous and Mental Disease, 172, 577–595.
Straub, R. E., Sullivan, P. F., Ma, Y., Myakishev, M. V., Harris-Kerr, C., Wormley, B., et al. (1999). Susceptibility genes for nicotine dependence: A genome scan and follow-up in an independent sample suggest that regions on chronosomes 2,
end p.745
|
|
|
|
